U.S., April 1 -- ClinicalTrials.gov registry received information related to the study (NCT07503496) titled 'Evaluation of the Efficacy of Biobran (Rice Bran Arabinoxylan) in Supporting Breast Cancer Chemotherapy' on March 19.
Brief Summary: This study aims to evaluate the potential supportive effects of rice bran arabinoxylan compound (Biobran) in patients with breast cancer receiving paclitaxel and doxorubicin chemotherapy. The study will assess chemotherapy-related side effects, quality of life, tumor size, tumor antigens, and routine blood test parameters over 24 weeks of treatment.
Study Start Date: April 07, 2025
Study Type: INTERVENTIONAL
Condition:
Breast Cancer Stages I
Breast Cancer Stages II
Breast Cancer Stage III
Interven...